A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

Enhancer RNAs (eRNAs) are intergenic long noncoding RNAs (lncRNAs) participating in the development of malignant cancers via targeting cancer-associated genes and immune checkpoints. Immune infiltration of the tumor microenvironment was positively associated with overall survival (OS) in lung adenoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Zhou, Shao-quan, Zhou, Yu, Lu, Jia-xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115606/
https://www.ncbi.nlm.nih.gov/pubmed/35600050
http://dx.doi.org/10.1155/2022/8069858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115606/
https://www.ncbi.nlm.nih.gov/pubmed/35600050
http://dx.doi.org/10.1155/2022/8069858

Ejemplares similares